176 related articles for article (PubMed ID: 10880402)
1. Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.
Washington C; Dalbègue F; Abreo F; Taubenberger JK; Lichy JH
Am J Pathol; 2000 Jul; 157(1):323-9. PubMed ID: 10880402
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast.
Selim AG; Ryan A; El-Ayat GA; Wells CA
Cancer Detect Prev; 2001; 25(3):262-7. PubMed ID: 11425268
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
5. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
6. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
[TBL] [Abstract][Full Text] [Related]
9. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis.
Selim AG; Ryan A; El-Ayat G; Wells CA
J Pathol; 2002 Mar; 196(3):287-91. PubMed ID: 11857491
[TBL] [Abstract][Full Text] [Related]
11. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Aaman TB; Stalsberg H; Thomas DB
Int J Cancer; 1997 May; 71(3):333-9. PubMed ID: 9139863
[TBL] [Abstract][Full Text] [Related]
12. The Histologic Spectrum of Apocrine Lesions of the Breast.
Durham JR; Fechner RE
Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
14. The microenvironment of human breast with clinical cancer.
Sarnelli R; Squartini F
Appl Pathol; 1983; 1(6):323-32. PubMed ID: 6679791
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
Cîmpean AM; Raica M; Nariţa D
Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
[TBL] [Abstract][Full Text] [Related]
16. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer.
Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH
Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575
[TBL] [Abstract][Full Text] [Related]
17. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
Seidman JD; Ashton M; Lefkowitz M
Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D-1 protein over-expression is not associated with gene amplification in benign and atypical apocrine lesions of the breast.
Elayat G; Selim AG; Gorman P; Tomlinson I; Wells CA
Pathol Res Pract; 2011 Feb; 207(2):75-8. PubMed ID: 21159451
[TBL] [Abstract][Full Text] [Related]
19. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
20. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
Moinfar F; Man YG; Arnould L; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer Res; 2000 May; 60(9):2562-6. PubMed ID: 10811140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
